Latest News

Opinion: A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution

A rare bright spot followed the emergence of Covid-19 and its spread across the globe: the discovery that remdesivir, an experimental antiviral originally developed by Gilead Sciences and the U.S. government for use against Ebola, works against SARS-CoV-2, the virus that causes Covid-19.

Remdesivir isn’t a miracle drug. It has not been proven to significantly reduce patients’ risk of dying from Covid-19, though evidence from an NIH-led clinical trial indicates that it helps patients with severe Covid-19 recover more quickly, meaning they can leave the hospital sooner and return home. We urgently need more and better evidence of remdesivir’s (likely modest) benefits.

Read the rest…

Source link

WordPress database error: [Error writing file '/tmp/MYPA5V2g' (Errcode: 28 - No space left on device)]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (389529) AND ( wp_term_relationships.term_taxonomy_id IN (2) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY RAND() LIMIT 0, 3

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy